MD biotechs queue for tax credits

Representatives from Maryland biotechnology start-ups made like potential contestants for __The Price is Right__ last Monday (June 30) and camped on a Baltimore sidewalk awaiting a chance at success. But these people weren't desperate to participate in the greatest game show on Earth, with a chance to win fabulous cash and prizes. They were lined up for a chance to suckle at the teat of the state's Department of Business and Economic Development, which was passing out state tax credits to biotec

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Representatives from Maryland biotechnology start-ups made like potential contestants for __The Price is Right__ last Monday (June 30) and camped on a Baltimore sidewalk awaiting a chance at success. But these people weren't desperate to participate in the greatest game show on Earth, with a chance to win fabulous cash and prizes. They were lined up for a chance to suckle at the teat of the state's Department of Business and Economic Development, which was passing out state tax credits to biotechs on a first-come, first-served basis as part of a program designed to encourage Maryland's emerging biotech sector. According to the linkurl:__Washington Post__,;http://www.washingtonpost.com/wp-dyn/content/article/2008/07/06/AR2008070601577.html?wpisrc=newsletter which sent a reporter down to the queue outside the Department of Business and Economic Development on East Redwood Street in Baltimore, several executives and scientists waited in line - some for up to 17 hours - to submit their applications for Maryland's Biotechnology Investment Tax Credit program. The program awards investors in small biotech companies in the state up to 50 percent of their money back in tax credits. This year's pool of money is $6 million, but Maryland's governor, linkurl:Martin O'Malley,;http://www.the-scientist.com/blog/display/54752/ told the __Post__ that next year's will be $12 million, and the program will offer $24 million in 2013. This year is the third that the state's biotech start-ups have had the opportunity to participate in the program, which is similar to programs in other states including Wisconsin, Washington, North Carolina, Massachusetts, and New York. According to the __Post,__ last week was the first time that biotech representatives have camped out for a shot at the Maryland tax incentives.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo